Peter Soparkar

Companies

• Avalanche BiotechnologiesChief operating officer Mar 3, 2023 to now¹
• Avalanche BiotechnologiesOfficer Aug 10, 2021 to Sep 21, 2022²
• Avalanche BiotechnologiesGeneral counsel Nov 1, 2019 to Feb 18, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABAvalanche Biotechnologies ADVM0 shares⁴Dec 9, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 9, 2025U 157,333 shares of Avalanche Biotechnologies⁴
• Dec 9, 2025Granted 150,000 shares of Avalanche Biotechnologies⁴
• Dec 9, 2025U 13,125 shares of Avalanche Biotechnologies⁴
• Dec 9, 2025U 80,189 shares of Avalanche Biotechnologies⁴
• Dec 5, 2025Bought 50,000 shares at $4.22 of Avalanche Biotechnologies⁵
• May 15, 2025Sold 2,960 shares at $2.00 of Avalanche Biotechnologies⁶
• Feb 25, 2025Granted 13,125 shares of Avalanche Biotechnologies⁷
• Mar 15, 2023Sold 13,360 shares at $0.78 of Avalanche Biotechnologies⁸
• Sep 19, 2022Sold 13,305 shares at $1.07 of Avalanche Biotechnologies⁹
• Apr 19, 2022Bought 21,750 shares at $1.14 of Avalanche Biotechnologies¹⁰
• Apr 19, 2022Bought 175 shares at $1.14 of Avalanche Biotechnologies¹⁰
• Dec 8, 2021Bought 25,000 shares at $1.91 of Avalanche Biotechnologies¹¹